Subscribe to RSS
Download PDF
DOI: 10.4103/ijmpo.ijmpo_147_18
A Report of a Rare Case of Hurthle Cell Carcinoma of Thyroid with Metachronous Renal Metastasis
Financial support and sponsorship Nil.
Abstract
Renal metastasis from Hurthle cell thyroid carcinoma is an extremely rare phenomenon which when present usually indicates widely disseminated disease. Herein, we present a case of Hurthle cell carcinoma of thyroid in a 58-year-old gentle lady, with metachronous renal metastasis which happens to be the fourth reported case in English literature.
Publication History
Received: 06 July 2018
Accepted: 12 September 2018
Article published online:
28 June 2021
© 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Bhattacharyya N. Survival and prognosis in Hürthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg 2003; 129: 207-10
- 2 Djekidel M, Gordon M, Shah RB, Gross MD, Avram A. Renal metastasis from Hurthle cell thyroid carcinoma and its evaluation with hybrid imaging. Thyroid 2010; 20: 429-33
- 3 Zhang H, Zeng L, Liang C, Qiu H, Zhang M, Zhu Y. et al. Successful treatment of Hurthle cell thyroid carcinoma with lung and liver metastasis using docetaxel and cisplatin. Jpn J Clin Oncol 2012; 42: 1086-90
- 4 Claimon M, Suh M, Cheon GJ, Lee DS, Kim EE, Chung JK. et al. Bilateral renal metastasis of Hürthle cell thyroid cancer with discordant uptake between I-131 sodium iodide and F-18 FDG. Nucl Med Mol Imaging 2017; 51: 256-60
- 5 Besic N, Schwarzbartl-Pevec A, Vidergar-Kralj B, Crnic T, Gazic B, Marolt Music M. et al. Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: A single-institution experience. BMC Cancer 2016; 16: 162
- 6 Kushchayeva Y, Duh QY, Kebebew E, Clark OH. Prognostic indications for Hürthle cell cancer. World J Surg 2004; 28: 1266-70
- 7 Watson RG, Brennan MD, Goellner JR, van Heerden JR, McConahey WM, Taylor WF. et al. Invasive Hürthle cell carcinoma of the thyroid: Natural history and management. Mayo Clin Proc 1984; 59: 851-5
- 8 Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG. et al. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 2003; 97: 1186-94
- 9 Haugen BR, Sherman SI. Evolving approaches to patients with advanced differentiated thyroid cancer. Endocr Rev 2013; 34: 439-55